| FDA New, GMP Do Clinical Phase II, III Intermediates GMP Custom synthesis, Full Document R&D Center: 8000 sq, More than 100 hoods Pilot Plant: 20000sq, 40 reactors from 5-200L Manufacturing Site: 800000sq, 40 reactors from 100-5000L Web: www.eosmedchem.com Email: info@eosmedchem.com; eosmedchem@gmail.com This is my R&D youtube: https://youtu.be/r5cJdXKNXHk |
| Sembragiline, 676479-06-4, Sembragiline Intermediate 117752-82-6, stock 190.4g, white powder, assay by HPLC 100%, HNMR, LCMS we supply. |
| Sembragiline, 676479-06-4, Sembragiline Intermediate 754228-95-0, stock 407.2g, white powder, assay by HPLC 99.9%, HNMR, LCMS we supply. |
| Sembragiline, 676479-06-4, Sembragiline Intermediate 57181-87-0, stock 435.2g, white powder, assay by HPLC 99.6%, HNMR, LCMS we supply. |
| Sembragiline, 676479-06-4, Sembragiline Intermediate 910301-98-3, stock 393.4g, white powder, assay by HPLC 98%, HNMR, LCMS we supply. |
| Sembragiline, 676479-06-4, Sembragiline Intermediate 1709830-59-0, stock 474.2g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply. |
| Sembragiline, 676479-06-4, Sembragiline Intermediate 123-30-8, stock 678.2g, white powder, assay by HPLC 98.2%, HNMR, LCMS we supply. |
| Sembragiline, 676479-06-4, Sembragiline Intermediate 456-42-8, stock 929.5g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
| Sembragiline, 676479-06-4, Sembragiline Intermediate /, stock 883.5g, white powder, assay by HPLC 99.6%, HNMR, LCMS we supply. |
